Nuvalent (NUVL) Change in Cash (2020 - 2026)
Nuvalent (NUVL) reported Change in Cash of -$102.0 million for Q1 2026, down 310.41% on a YoY basis from $48.5 million in Q1 2025, and down 169.87% quarter-over-quarter from $146.0 million in Q4 2025.
Nuvalent (NUVL) Change in Cash (2020 - 2026) Analysis & Trends
Nuvalent has reported Change in Cash for 7 years, with the latest figure at -$102.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash fell 310.41% year-over-year to -$102.0 million; the trailing twelve-month figure through Mar 2026 stood at $38.9 million (up 74.27% YoY), and the FY2025 full-year result was $116.1 million, up 161.18% from the prior year.
- Change in Cash for Q1 2026 stood at -$102.0 million, down from $146.0 million in the prior quarter.
- The five-year high for Change in Cash was $291.5 million in Q3 2024, with the low at -$236.9 million in Q1 2024.
- Historically, Change in Cash has averaged $5.4 million across 5 years, with a median of -$1.3 million in 2022.
- The largest YoY upside for Change in Cash was 4312.56% in 2023 against a maximum downside of 12006.23% in 2023.
- Nuvalent's Change in Cash stood at $165.5 million in 2022, then soared by 49.22% to $247.0 million in 2023, then slumped by 190.52% to -$223.6 million in 2024, then jumped by 165.31% to $146.0 million in 2025, then tumbled by 169.87% to -$102.0 million in 2026.
- The last three Change in Cash figures came in at -$102.0 million (Q1 2026), $146.0 million (Q4 2025), and -$11.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -45.97 Mn |
| 10 | Nuvalent | 9.70 Bn | 9.70 Bn | - | -102.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -102.01 Mn |
| Dec 31, 2025 | 145.99 Mn |
| Sep 30, 2025 | -11.72 Mn |
| Jun 30, 2025 | 6.64 Mn |
| Mar 31, 2025 | -24.86 Mn |
| Dec 31, 2024 | -223.55 Mn |
| Sep 30, 2024 | 291.54 Mn |
| Jun 30, 2024 | -20.82 Mn |
| Mar 31, 2024 | -236.87 Mn |
| Dec 31, 2023 | 246.95 Mn |
| Sep 30, 2023 | 17.56 Mn |
| Jun 30, 2023 | -19.24 Mn |
| Mar 31, 2023 | -151.69 Mn |
| Dec 31, 2022 | 165.49 Mn |
| Sep 30, 2022 | 398,000.00 |
| Jun 30, 2022 | 8.64 Mn |
| Mar 31, 2022 | -1.25 Mn |
| Dec 31, 2021 | -177.36 Mn |
| Sep 30, 2021 | 106.97 Mn |
| Jun 30, 2021 | 124.52 Mn |